Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

NCT02289417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

Amgen